Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients
NCT02390206 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 239
Last updated 2017-10-02
Summary
The purpose of this study is to document the effectiveness of treating chronic post-stroke spastic patients with Botulinum Toxin type A.
Conditions
- Spasticity
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Ipsen Study Director · Ipsen
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2017-08-28
- Completion
- 2017-08-28
Countries
- Brazil
Study Locations
More Related Trials
-
ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Limb Spasticity
NCT02275312 ·Status: COMPLETED
-
Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
NCT00819065 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke
NCT01910363 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
NCT01444794 ·Status: COMPLETED
-
A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke
NCT01239628 ·Status: TERMINATED
-
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke
NCT01464307 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.
NCT05224349 ·Status: COMPLETED
-
Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort
NCT04050527 ·Status: COMPLETED
-
To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke
NCT01020500 ·Status: COMPLETED
-
CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY
NCT04673240 ·Status: UNKNOWN
-
The Effectiveness of Early Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke Adults
NCT02505802 ·Status: UNKNOWN ·Phase: PHASE4
-
BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity
NCT01575054 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01603459 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA
NCT04446702 ·Status: COMPLETED
-
BOTOX® Treatment in Pediatric Lower Limb Spasticity
NCT01603628 ·Status: COMPLETED ·Phase: PHASE3
-
Muscle Selection for Botulinum Toxin A Injection in Poststroke Elbow Flexor Spasticity
NCT04036981 ·Status: COMPLETED
-
Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence
NCT06811142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Early Use of Botulinum Toxin in Spasticity Post Stroke.
NCT01882556 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment
NCT00651690 ·Status: COMPLETED ·Phase: PHASE2
-
Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
NCT02454803 ·Status: COMPLETED
-
Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity
NCT01387074 ·Status: COMPLETED
-
Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia
NCT02604186 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
NCT00076687 ·Status: COMPLETED ·Phase: PHASE2
-
BOTOX® Treatment in Pediatric Upper Limb Spasticity
NCT01603602 ·Status: COMPLETED ·Phase: PHASE3